v3 Template
C

CREATE Medicines, Inc.

Biotechnology / Immunotherapy ~220 employees
Founded
--
Employees (Est.)
~220
11 leaders known
Total Funding
$122.0M
Funding Rounds
1
Last Funding
2026-05-14

About CREATE Medicines, Inc.

CREATE Medicines is pioneering multi-immune programming with its versatile in vivo CAR platform. The company focuses on engineering cures from within by programming immune cells such as T cells, NK cells, and myeloid cells directly in the body using proprietary mRNA-LNP CARs and targeted receptor/LNP technologies. Their mission is to unlock scalable, off-the-shelf therapies with speed, lower costs, and broader patient access across cancer, autoimmunity, and fibrosis.

Products & Services

In Vivo CAR Platform:A versatile platform using mRNA-LNP CARs and targeted receptor/LNP technologies to program multiple immune cell types (T, NK, myeloid) within the body, with demonstrated tolerability and first-in-human evidence.
MT-303:A novel GPC3-targeting RNA CAR for advanced hepatocellular carcinoma (HCC), currently in Phase 1 study with patient dosing initiated.
CRT-402
CRT-403
RetroT
MT-302
MT-303
MT-304
CRT-401

Specialties

Multi-immune programming In vivo CAR therapies RNA engineering Selective receptor design Targeted LNP delivery Immunology multi-immune programming in vivo CAR platform mRNA-LNP CARs targeted receptor/LNP technologies T/NK/myeloid cell programming

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series B
T: -
FT: Series B
A: 122000000
MR: -
FA: $122 million
FAN: 122000000
D: 2026-05-14
FD: 2026-05-14
4 investors
Series B Latest
2026-05-14
$122.0M
4 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

D

Daniel Getts

Chief Executive Officer, Cofounder, Board Director

B

Brett Kaplan

Chief Financial Officer and Chief Business Officer

M

Matthew Maurer

Chief Medical Officer

R

Robert Hofmeister

Chief Scientific Officer

J

Jerome Chal

Chief Technology Officer

C

Curtis Demick

Chief People Officer

View 8 more team members with Pro

Unlock Full Team Directory

Recent News

CREATE Medicines, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Immunotherapy
Company Size
~220 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro